Abstract
Cathepsin L was purified to apparent homogeneity from human liver obtained post mortem. It was necessary to treat the homogenate at pH 4.2 and 37 degrees C to release active enzyme. The purification procedure involved ion-exchange chromatography on carboxymethyl-Sephadex and the Mono S column of a Pharmacia fast-protein-liquid-chromatography system. The enzyme was found to consist of two polypeptide chains of Mr 25 000 and 5000. The larger chain was shown to contain the active-site cysteine residue. Human cathepsin L proved to be similar to the rat and rabbit enzymes in regard to kinetic constants for the substrate benzyloxycarbonylphenylalanylarginine 7-(4-methyl)coumarylamide and rates of inactivation by the active-site-directed reagents benzyloxycarbonylphenylalanylphenylalanyldiazomethane and benzyloxycarbonylphenylalanylalanyldiazomethane. Thus clear characteristics of cathepsin L are now emerging, and these should simplify the identification of the enzyme in other tissues and species.
Full text
PDF








Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett A. J., Kembhavi A. A., Brown M. A., Kirschke H., Knight C. G., Tamai M., Hanada K. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982 Jan 1;201(1):189–198. doi: 10.1042/bj2010189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barrett A. J., Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 1981;80(Pt 100):535–561. doi: 10.1016/s0076-6879(81)80043-2. [DOI] [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Davies M. E., Barrett A. J. Immunolocalization of human cystatins in neutrophils and lymphocytes. Histochemistry. 1984;80(4):373–377. doi: 10.1007/BF00495420. [DOI] [PubMed] [Google Scholar]
- Etherington D. J., Mason R. W., Taylor M. A., Wardale R. J. Production of a monospecific antiserum to cathepsin L: the histochemical location of enzyme in rabbit fibroblasts. Biosci Rep. 1984 Feb;4(2):121–127. doi: 10.1007/BF01120308. [DOI] [PubMed] [Google Scholar]
- Evans P., Etherington D. J. Characterisation of cathepsin B and collagenolytic cathepsin from human placenta. Eur J Biochem. 1978 Feb 1;83(1):87–97. doi: 10.1111/j.1432-1033.1978.tb12071.x. [DOI] [PubMed] [Google Scholar]
- Goodman D., Matzura H. An improved method of counting radioactive acrylamide gels. Anal Biochem. 1971 Aug;42(2):481–486. doi: 10.1016/0003-2697(71)90062-5. [DOI] [PubMed] [Google Scholar]
- Gounaris A. D., Brown M. A., Barrett A. J. Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment. Biochem J. 1984 Jul 15;221(2):445–452. doi: 10.1042/bj2210445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green G. D., Kembhavi A. A., Davies M. E., Barrett A. J. Cystatin-like cysteine proteinase inhibitors from human liver. Biochem J. 1984 Mar 15;218(3):939–946. doi: 10.1042/bj2180939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henderson P. J. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J. 1972 Apr;127(2):321–333. doi: 10.1042/bj1270321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katunuma N., Towatari T., Tamai M., Hanada K. Use of new synthetic substrates for assays of cathepsin L and cathepsin B. J Biochem. 1983 Apr;93(4):1129–1135. doi: 10.1093/oxfordjournals.jbchem.a134238. [DOI] [PubMed] [Google Scholar]
- Kirschke H., Kembhavi A. A., Bohley P., Barrett A. J. Action of rat liver cathepsin L on collagen and other substrates. Biochem J. 1982 Feb 1;201(2):367–372. doi: 10.1042/bj2010367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirschke H., Langner J., Riemann S., Wiederanders B., Ansorge S., Bohley P. Lysosomal cysteine proteinases. Ciba Found Symp. 1979;(75):15–35. doi: 10.1002/9780470720585.ch2. [DOI] [PubMed] [Google Scholar]
- Kirschke H., Langner J., Wiederanders B., Ansorge S., Bohley P. Cathepsin L. A new proteinase from rat-liver lysosomes. Eur J Biochem. 1977 Apr 1;74(2):293–301. doi: 10.1111/j.1432-1033.1977.tb11393.x. [DOI] [PubMed] [Google Scholar]
- Kirschke H., Locnikar P., Turk V. Species variations amongst lysosomal cysteine proteinases. FEBS Lett. 1984 Aug 20;174(1):123–127. doi: 10.1016/0014-5793(84)81089-3. [DOI] [PubMed] [Google Scholar]
- Kirschke H., Shaw E. Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2. Biochem Biophys Res Commun. 1981 Jul 30;101(2):454–458. doi: 10.1016/0006-291x(81)91281-x. [DOI] [PubMed] [Google Scholar]
- Knight C. G. Human cathepsin B. Application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin. Biochem J. 1980 Sep 1;189(3):447–453. doi: 10.1042/bj1890447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mason R. W., Taylor M. A., Etherington D. J. Purification and characterisation of collagenolytic cathepsins from rabbit liver. FEBS Lett. 1982 Sep 6;146(1):33–36. doi: 10.1016/0014-5793(82)80699-6. [DOI] [PubMed] [Google Scholar]
- Mason R. W., Taylor M. A., Etherington D. J. The purification and properties of cathepsin L from rabbit liver. Biochem J. 1984 Jan 1;217(1):209–217. doi: 10.1042/bj2170209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murawaki Y., Hirayama C. Hepatic collagenolytic cathepsin in patients with chronic liver disease. Clin Chim Acta. 1980 Nov 20;108(1):121–128. doi: 10.1016/0009-8981(80)90300-9. [DOI] [PubMed] [Google Scholar]
- Pagano M., Engler R. Inhibition of human liver cathepsin L by alpha-thiol proteinase inhibitor. FEBS Lett. 1982 Feb 22;138(2):307–310. doi: 10.1016/0014-5793(82)80467-5. [DOI] [PubMed] [Google Scholar]
- Pagano M., Esnard F., Engler R., Gauthier F. Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum. Biochem J. 1984 May 15;220(1):147–155. doi: 10.1042/bj2200147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riemann S., Kirschke H., Wiederanders B., Brouwer A., Shaw E., Bohley P. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver. Acta Biol Med Ger. 1982;41(1):83–88. [PubMed] [Google Scholar]
- Schwartz W. N., Barrett A. J. Human cathepsin H. Biochem J. 1980 Nov 1;191(2):487–497. doi: 10.1042/bj1910487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takio K., Towatari T., Katunuma N., Titani K. Primary structure study of rat liver cathepsin B -- a striking resemblance to papain. Biochem Biophys Res Commun. 1980 Nov 17;97(1):340–346. doi: 10.1016/s0006-291x(80)80173-2. [DOI] [PubMed] [Google Scholar]
- Thomas G. J., Hughes K. T., Davies M. The isolation of three thiol proteinases from human kidney that attack glomerular basement membrane. Biochem Soc Trans. 1980 Oct;8(5):596–597. doi: 10.1042/bst0080596. [DOI] [PubMed] [Google Scholar]
- Thompson R. C., Blout E. R. Peptide chloromethyl ketones as irreversible inhibitors of elastase. Biochemistry. 1973 Jan 2;12(1):44–47. doi: 10.1021/bi00725a008. [DOI] [PubMed] [Google Scholar]
- Tian W. X., Tsou C. L. Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry. 1982 Mar 2;21(5):1028–1032. doi: 10.1021/bi00534a031. [DOI] [PubMed] [Google Scholar]
- WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]

